A brief measure for assessing generalized anxiety disorder: the GAD-7.
By R. Spitzer, K. Kroenke, Janet B W Williams, B. Löwe. Archives of Internal Medicine, 2006
29,398 citations recorded by the source corpus.
Subfields: Clinical Psychology, Experimental and Cognitive Psychology
View Paper: https://www.semanticscholar.org/paper/fb69564112288c3999e0633e1ba8eae7f03328e9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
- B. Löwe
- K. Kroenke
- Janet B W Williams
- R. Spitzer
- David L. Dawson
- Nima Golijani-Moghaddam
- Sherman A. Lee
- Jeffrey S Ashby
In Experimental and Cognitive Psychology
- B. Löwe
- K. Kroenke
- R. Spitzer
- Janet B W Williams
- Sherman A. Lee
- Kenneth G. Rice
- Jeffrey S Ashby
- Nima Golijani-Moghaddam
Citations in the corpus
- Depression and anxiety among university students during the COVID-19 pandemic in Bangladesh: A web-based cross-sectional survey (2020, methodology): “In the questionnaire, the questions were used for screening anxiety state of an individual on a scale ranging from ‘0 = not at all sure’ to ‘3 = nearly every day’ [32].”
- Gender inequality in COVID-19 times: evidence from UK prolific participants (2020, background): “It follows the DSM-IV diagnostic criteria for generalized anxiety disorder and is sensitive to the presence of social phobia, panic disorder and post-traumatic stress disorder (Spitzer et al. 2006).”
- Gender Differences in Work-Family Guilt in Parents of Young Children (2017, background): “001 (Guilt and Shame Proneness Scale; Cohen et al. 2011); attachment anxiety, r= .22, p= .”
- How Adolescents Use Social Media to Cope with Feelings of Loneliness and Anxiety During COVID-19 Lockdown (2020, neutral): “43 Loneliness was measured by a 6-item scale (RULS-6).”
- Revisión de estudios de la Escala de Ansiedad y Depresión Hospitalaria (HAD) en muestras españolas (2015, background): “Esto, unido a la ambigüedad de la estructura factorial del HAD y la parte común que pueden compartir las subescalas del HAD, PHQ-9 y GAD-7, podría apoyar cierta preferencia hacia estos dos últimos en la práctica clínica (Kendel et al., 2010; Norton et al., 2012; Spitzer et al., 2006).”
- Harnessing Context Sensing to Develop a Mobile Intervention for Depression (2011, methodology): “GAD-7: Generalized Anxiety Disorder 7-item scale GPS: global positioning system PHQ: Patient Health Questionnaire QIDS-C: Quick Inventory of Depression Symptoms–Clinician Rated SMS: short message service XMPP: extensible messaging and presence protocol Edited by G Eysenbach; submitted 26.04.11; peer”
- DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. (2013, background): “generalized anxiety disorder (the GAD-7 [37]), and somatization disorder (the PHQ-15 [38]).”
- The Personalization of Conversational Agents in Health Care: Systematic Review (2019, background): “03) and significant differences in the posi• Questionnaires to measure depression (PHQ-9a) [48], anxiety (GAD-7b) [49], and affect • To improve depression and anxiety symptoms • To provide more engaging and convenient user experitive and negative affects (P=.”
- The Global Prevalence of Anxiety Among Medical Students: A Meta-Analysis (2019, methodology): “As a comparison, the prevalence of anxiety among the general population was found to be 3% as screened by the DASS-21 [96], 8.2% as screened by the GAD-7 [97], not more than 10% as screened by the BAI-21 [98] and not more than 25% as screened by the HADS-A [99].”
- Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial (2017, methodology): “The Generalized Anxiety Disorder 7-item scale (GAD-7) [20] is a valid, brief self-report tool to assess the frequency and severity of anxious thoughts and behaviors over the past 2 weeks.”
- Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey (2020, background): “The total score of GAD-7 ranged from 0 to 21, with increasing scores indicating more severe functional impairments as a result of anxiety (Spitzer et al., 2006).”
- Network Analysis of Depression and Anxiety Symptom Relations in a Psychiatric Sample (2016, methodology): “2001) and the 7-item Generalized Anxiety Disorder Scale (GAD-7; Spitzer et al. 2006), self-report measures of depression and anxiety symptom severity, respectively, over the prior 2 weeks.”